Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 75,651 | 49 | 44 | 38,345 | 0 |
Gross Profit | 75,651 | 49 | 44 | 38,345 | N/A |
Operating Expenses | 73,943 | 77,719 | 71,073 | 71,546 | 69,362 |
Operating Income | 1,708 | -77,670 | -71,029 | -33,201 | -69,362 |
Other Income | -1,622 | -516 | 93 | 186 | -65,368 |
Pre-tax Income | 86 | -78,186 | -70,936 | -33,015 | -134,730 |
Net Income Continuous | 86 | -78,186 | -70,936 | -33,015 | -134,730 |
Net Income | $86 | $-78,186 | $-70,936 | $-33,015 | $-134,730 |
EPS Basic Total Ops | 0.01 | -0.57 | -0.53 | -0.25 | -1.08 |
EPS Basic Continuous Ops | 0.01 | -0.57 | -0.53 | -0.25 | -1.08 |
EPS Diluted Total Ops | 0.01 | -0.57 | -0.53 | -0.25 | -1.08 |
EPS Diluted Continuous Ops | 0.01 | -0.57 | -0.53 | -0.25 | -1.08 |
EBITDA(a) | $7,544 | $-73,725 | $-67,230 | $-29,372 | $-65,705 |